We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
476
MetLife
MET
$61.7B
$374K 0.07%
+5,048
New +$352K
FORM icon
477
FormFactor
FORM
$8.79B
$373K 0.07%
+8,181
New +$341K
NXRT
478
NexPoint Residential Trust
NXRT
$641M
$371K 0.07%
+11,527
New +$358K
RLAY icon
479
Relay Therapeutics
RLAY
$4.37B
$371K 0.07%
+44,692
New +$436K
MATX icon
480
Matsons
MATX
$6.24B
$370K 0.07%
+3,293
New +$371K
PFS icon
481
Provident Financial Services
PFS
$3.17B
$369K 0.07%
+25,344
New +$403K
MA icon
482
Mastercard
MA
$493B
$369K 0.07%
+766
New +$350K
CALX icon
483
Calix
CALX
$2.4B
$367K 0.07%
+11,062
New +$412K
FLNC icon
484
Fluence Energy
FLNC
$2.34B
$366K 0.07%
+21,103
New +$386K
LGF.B
485
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$365K 0.07%
+39,251
New +$363K
ADMA icon
486
ADMA Biologics
ADMA
$2.18B
$365K 0.07%
55,304
+41,357
+297% +$226K
FLIC
487
DELISTED
First of Long Island Corp
FLIC
$365K 0.07%
+32,889
New +$383K
BXP icon
488
Boston Properties
BXP
$10.8B
$364K 0.07%
5,575
+1,844
+49% +$122K
RVNC
489
DELISTED
Revance Therapeutics, Inc.
RVNC
$362K 0.07%
+73,524
New +$435K
PLCE icon
490
Children's Place
PLCE
$58.3M
$362K 0.07%
+31,343
New +$593K
UTMD icon
491
Utah Medical Products
UTMD
$227M
$360K 0.07%
+5,064
New +$380K
FDX icon
492
FedEx
FDX
$76.9B
$358K 0.07%
+1,236
New +$309K
RUN icon
493
Sunrun
RUN
$2.38B
$358K 0.07%
+27,163
New +$373K
AMH icon
494
American Homes 4 Rent
AMH
$12.3B
$357K 0.07%
9,710
-2,677
-22% -$95.6K
EVR icon
495
Evercore
EVR
$11.5B
$356K 0.07%
1,848
+446
+32% +$80.7K
SEAT icon
496
Vivid Seats
SEAT
$82.6M
$355K 0.07%
+2,966
New +$348K
BLDR icon
497
Builders FirstSource
BLDR
$7.74B
$355K 0.07%
+1,700
New +$314K
HNI icon
498
HNI Corp
HNI
$3.54B
$354K 0.07%
+7,854
New +$333K
BLD
499
DELISTED
TopBuild
BLD
$354K 0.07%
+804
New +$314K
HAIN icon
500
Hain Celestial
HAIN
$53.4M
$353K 0.07%
+44,951
New +$443K
18 19
20
21 22

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.